It is a start, maybe. Remdesivir is being touted as a potentially more effective drug. The Chinese had reported there were several pharmaceuticals which appeared to work also and in particular drugs for malaria, Chloroquine and HydoxyChloroquine. I had mentioned this earlier in the week in a post and then again in two separate comments. One small clinical test (preliminary trial with 24 -36 patients) in France had positive results recently as reported March 17, 2020. HydoxyChloroquine Would Be Effective According to Professor Roault of the IHU in Marseille,” after the first limited Test as reported by EN24 on March 17, 2020. With the use of the antibiotic Azithromycin to treat pneumonia a bacterial infection resulting from the virus infection, the test
Topics:
run75441 considers the following as important: Healthcare, politics
This could be interesting, too:
Peter Radford writes Election: Take Four
Joel Eissenberg writes Diversity in healthcare delivery
Angry Bear writes Heathcare Insurance Companies Abandoning Medicare Advantage
Joel Eissenberg writes Access to medical care: right or privilege?
It is a start, maybe. Remdesivir is being touted as a potentially more effective drug.
The Chinese had reported there were several pharmaceuticals which appeared to work also and in particular drugs for malaria, Chloroquine and HydoxyChloroquine. I had mentioned this earlier in the week in a post and then again in two separate comments.
One small clinical test (preliminary trial with 24 -36 patients) in France had positive results recently as reported March 17, 2020. HydoxyChloroquine Would Be Effective According to Professor Roault of the IHU in Marseille,” after the first limited Test as reported by EN24 on March 17, 2020. With the use of the antibiotic Azithromycin to treat pneumonia a bacterial infection resulting from the virus infection, the test results were 75% positive.
Remdesivir appears to have worked in a limited number of cases also. An issue which we are missing is bacterial infection following viral infection. The Chinese followed up their treatment using Chloroquine and HydoxyChloroquine (decades old drug) with antibiotics for Strep. The French study instead uses Azithromycin for treatment of the resulting pneumonia. Although the French clinical test had a success rate of 75%, they are calling for a larger load testing. For Italy, it may present an opportunity sooner than Remdesivir.
And today, Trump is back on the air: Malaria Drug for Coronavirus Has Been Approved by FDA (?)
President Donald Trump announced Thursday the Food and Drug Administration (FDA) has approved hydroxychloroquine—a drug used to treat malaria, rheumatic diseases and other conditions—for COVID-19.
As the COVID-19 pandemic spreads around the world, scientists are scrambling to identify treatments that may be effective against the disease. Hydroxychloroquine—a common derivative of chloroquine—is among those touted as most promising by some experts.
“HydoxyChloroquine Would Be Effective According to Professor Roault of the IHU in Marseille after the first limited Test,” EN24, March 17, 2020
Donald Trump Says Malaria Drug for Coronavirus Has Been Approved by FDA, Newsweek, Aristos Georgiou, March 19, 2020
Update As soon as Trump said HydoxyChloroquine was approved, FDA Head Steven Hahn contradicted Mr. Trump saying the president had “directed the FDA to take a closer took” at whether the drug could help people with coronavirus. In an indication the FDA had not approved HydoxyChloroquine for use yet, Mr. Hahn called for large clinical trials.
“FDA contradicts Trump on status of potential coronavirus drug,” Financial Times, Demetri Sevastopulo (Washington) and Hannah Kuchler (New York), March 19, 2020